AgilityBio And Advinus Therapeutics (P) Ltd. Announce Partnership to Introduce Digital Pathology Services in Pre Clinical Research  
11/5/2008 9:43:40 AM

CUPERTINO, Calif.--(BUSINESS WIRE)--AgilityBio, a division of BioImagene Inc, and Advinus Therapeutics, a TATA enterprise, announced a partnership that will enable providing imaging services in conjunction with preclinical development services offered by Advinus. This partnership will bring about a synergy between drug development at US based biotech and pharma industries and India's highly developed life sciences service industry. Advinus, a leading service provider of pre-clinical development services to the global Pharma and Biotech industry will combine its services with AgilityBio’s imaging services that use BioImagene’s cutting edge digital pathology solutions for cancer diagnosis and research.